Identifying the predictor of clinical efficacy and safety by genotype vs. phenotype in patients receiving clopidogrel underwent PCI

被引：0
|
作者：
Zhang Xiaoxing
Yuan Jinqing
Chen Jue
Gao Zhan
Qian Jie
Zhang Pei
Jia Youhong
Li Yishi
机构：
[1] CAMS, Fuwai Hosp, Minist Hlth, Key Lab Clin Trial Res Cardiovasc Drugs, Beijing, Peoples R China
[2] PUMC, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW25-e1655
引用
收藏
页码：C119 / C120
页数：2
相关论文
共 50 条
  • [1] Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study
    Siller-Matula, J. M.
    Delle-Karth, G.
    Lang, I. M.
    Neunteufl, T.
    Kozinski, M.
    Kubica, J.
    Maurer, G.
    Linkowska, K.
    Grzybowski, T.
    Huber, K.
    Jilma, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) : 529 - 542
  • [2] Efficacy and safety of clopidogrel added proton pump inhihibitors vs clopidogrel in the treatment of cardiovascular patients after PCI
    Pang, Jun
    CARDIOLOGY, 2013, 126 : 117 - 117
  • [3] Efficacy and safety of clopidogrel added proton pump inhihibitors vs clopidogrel in the treatment of cardiovascular patients after PCI
    Pang, Jun
    He, Qiqi
    Zhang, Hongling
    Li, Na
    Mu, Zhongyuan
    Bai, Min
    Qian, Dun
    Zhang, Zheng
    CARDIOLOGY, 2013, 126 : 148 - 149
  • [4] Safety and efficacy of NOAC vs. VKA in patients treated by PCI: a retrospective study of the FRANCE PCI registry
    Durand, Eric
    Verrez, Thibault
    Gillibert, Andre
    Levesque, Thomas
    Barbe, Thomas
    Koning, Rene
    Motreff, Pascal
    Eltchaninoff, Helene
    Collet, Jean-Philippe
    Range, Gregoire
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [5] Efficacy and Safety of Double Dosage of Clopidogrel in AMI Patients with Low Response to Clopidogrel Undergoing Delayed PCI
    Fu, Xianghua
    Jia Xinwei
    Huang Jingjing
    Gu Xinshun
    Fan Weize
    Wu Weili
    Li Shiqiang
    Jiang Yunfa
    Liu Jinjun
    CIRCULATION, 2008, 118 (18) : S820 - S820
  • [6] Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study
    Chang, Chi-Jen
    Tung, Ying-Chang
    Liu, Jia-Rou
    Chang, Shu-Hao
    Kuo, Chi-Tai
    See, Lai-Chu
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (02) : 443 - 451
  • [7] Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
    Bai, Long
    Yang, Xiao-Hong
    Zhou, Ya-Qing
    Cui, Xiao-Ran
    Fu, Ling-Zhi
    Zhang, Ji-Dong
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [8] Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
    Bai, Long
    Yang, Xiao-hong
    Zhou, Ya-qing
    Cui, Xiao-ran
    Fu, Ling-zhi
    Zhang, Ji-dong
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [9] Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
    Bai, Long
    Yang, Xiao-hong
    Zhou, Ya-qing
    Cui, Xiao-ran
    Fu, Ling-zhi
    Zhang, Ji-dong
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [10] Alirocumab Efficacy and Safety in Patients with Prediabetes vs. Normoglycemia
    Leiter, Lawrence A.
    Mueller-Wieland, Dirk
    Baccara-Dinet, Marie T.
    Letierce, Alexia
    Samuel, Rita
    Cariou, Bertrand
    DIABETES, 2016, 65 : A162 - A162
12345